vs
Side-by-side financial comparison of Dexcom (DXCM) and Trade Desk (The) (TTD). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $846.8M, roughly 1.5× Trade Desk (The)). Trade Desk (The) runs the higher net margin — 22.1% vs 21.2%, a 0.9% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 14.3%). Over the past eight quarters, Trade Desk (The)'s revenue compounded faster (31.3% CAGR vs 12.0%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
The Trade Desk, Inc. is an American multinational technology company that specializes in real-time programmatic marketing automation technologies, products, and services, designed to personalize digital content delivery to users.
DXCM vs TTD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $846.8M |
| Net Profit | $267.3M | $186.9M |
| Gross Margin | 62.9% | 80.7% |
| Operating Margin | 25.6% | 30.3% |
| Net Margin | 21.2% | 22.1% |
| Revenue YoY | 21.6% | 14.3% |
| Net Profit YoY | 153.6% | 2.6% |
| EPS (diluted) | $0.67 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $846.8M | ||
| Q3 25 | $1.2B | $739.4M | ||
| Q2 25 | $1.2B | $694.0M | ||
| Q1 25 | $1.0B | $616.0M | ||
| Q4 24 | $1.1B | $741.0M | ||
| Q3 24 | $994.2M | $628.0M | ||
| Q2 24 | $1.0B | $584.5M |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $186.9M | ||
| Q3 25 | $283.8M | $115.5M | ||
| Q2 25 | $179.8M | $90.1M | ||
| Q1 25 | $105.4M | $50.7M | ||
| Q4 24 | $151.7M | $182.2M | ||
| Q3 24 | $134.6M | $94.2M | ||
| Q2 24 | $143.5M | $85.0M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 80.7% | ||
| Q3 25 | 60.5% | 78.1% | ||
| Q2 25 | 59.5% | 78.2% | ||
| Q1 25 | 56.9% | 76.8% | ||
| Q4 24 | 58.9% | 81.7% | ||
| Q3 24 | 59.7% | 80.5% | ||
| Q2 24 | 62.4% | 81.1% |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 30.3% | ||
| Q3 25 | 20.1% | 21.8% | ||
| Q2 25 | 18.4% | 16.8% | ||
| Q1 25 | 12.9% | 8.8% | ||
| Q4 24 | 17.0% | 26.4% | ||
| Q3 24 | 15.3% | 17.3% | ||
| Q2 24 | 15.7% | 16.2% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 22.1% | ||
| Q3 25 | 23.5% | 15.6% | ||
| Q2 25 | 15.5% | 13.0% | ||
| Q1 25 | 10.2% | 8.2% | ||
| Q4 24 | 13.6% | 24.6% | ||
| Q3 24 | 13.5% | 15.0% | ||
| Q2 24 | 14.3% | 14.5% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $0.39 | ||
| Q3 25 | $0.70 | $0.23 | ||
| Q2 25 | $0.45 | $0.18 | ||
| Q1 25 | $0.27 | $0.10 | ||
| Q4 24 | $0.37 | $0.36 | ||
| Q3 24 | $0.34 | $0.19 | ||
| Q2 24 | $0.35 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $1.3B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $2.5B |
| Total Assets | $6.3B | $6.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $1.3B | ||
| Q3 25 | $1.8B | $1.4B | ||
| Q2 25 | $1.2B | $1.7B | ||
| Q1 25 | $904.9M | $1.7B | ||
| Q4 24 | $606.1M | $1.9B | ||
| Q3 24 | $621.2M | $1.7B | ||
| Q2 24 | $939.2M | $1.5B |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $2.5B | ||
| Q3 25 | $2.7B | $2.6B | ||
| Q2 25 | $2.6B | $2.7B | ||
| Q1 25 | $2.3B | $2.7B | ||
| Q4 24 | $2.1B | $2.9B | ||
| Q3 24 | $2.0B | $2.6B | ||
| Q2 24 | $2.4B | $2.4B |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $6.2B | ||
| Q3 25 | $7.5B | $5.9B | ||
| Q2 25 | $7.3B | $6.0B | ||
| Q1 25 | $6.8B | $5.7B | ||
| Q4 24 | $6.5B | $6.1B | ||
| Q3 24 | $6.4B | $5.5B | ||
| Q2 24 | $6.8B | $5.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $311.6M |
| Free Cash FlowOCF − Capex | — | $285.3M |
| FCF MarginFCF / Revenue | — | 33.7% |
| Capex IntensityCapex / Revenue | — | 3.1% |
| Cash ConversionOCF / Net Profit | — | 1.67× |
| TTM Free Cash FlowTrailing 4 quarters | — | $795.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $311.6M | ||
| Q3 25 | $659.9M | $224.7M | ||
| Q2 25 | $303.0M | $165.0M | ||
| Q1 25 | $183.8M | $291.4M | ||
| Q4 24 | $301.4M | $199.4M | ||
| Q3 24 | $199.5M | $273.3M | ||
| Q2 24 | $279.4M | $81.3M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $285.3M | ||
| Q3 25 | $579.4M | $158.3M | ||
| Q2 25 | $208.9M | $119.8M | ||
| Q1 25 | $96.8M | $232.3M | ||
| Q4 24 | $176.8M | $179.2M | ||
| Q3 24 | $88.3M | $224.6M | ||
| Q2 24 | $213.3M | $59.1M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 33.7% | ||
| Q3 25 | 47.9% | 21.4% | ||
| Q2 25 | 18.1% | 17.3% | ||
| Q1 25 | 9.3% | 37.7% | ||
| Q4 24 | 15.9% | 24.2% | ||
| Q3 24 | 8.9% | 35.8% | ||
| Q2 24 | 21.2% | 10.1% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 3.1% | ||
| Q3 25 | 6.7% | 9.0% | ||
| Q2 25 | 8.1% | 6.5% | ||
| Q1 25 | 8.4% | 9.6% | ||
| Q4 24 | 11.2% | 2.7% | ||
| Q3 24 | 11.2% | 7.8% | ||
| Q2 24 | 6.6% | 3.8% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 1.67× | ||
| Q3 25 | 2.33× | 1.94× | ||
| Q2 25 | 1.69× | 1.83× | ||
| Q1 25 | 1.74× | 5.75× | ||
| Q4 24 | 1.99× | 1.09× | ||
| Q3 24 | 1.48× | 2.90× | ||
| Q2 24 | 1.95× | 0.96× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
TTD
| Other | $427.2M | 50% |
| Non Us | $419.6M | 50% |
